1. Home
  2. ILMN vs TU Comparison

ILMN vs TU Comparison

Compare ILMN & TU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILMN
  • TU
  • Stock Information
  • Founded
  • ILMN 1998
  • TU 1993
  • Country
  • ILMN United States
  • TU Canada
  • Employees
  • ILMN 9300
  • TU N/A
  • Industry
  • ILMN Medical Specialities
  • TU Telecommunications Equipment
  • Sector
  • ILMN Health Care
  • TU Telecommunications
  • Exchange
  • ILMN Nasdaq
  • TU Nasdaq
  • Market Cap
  • ILMN 22.9B
  • TU 23.9B
  • IPO Year
  • ILMN 2000
  • TU N/A
  • Fundamental
  • Price
  • ILMN $144.14
  • TU $15.57
  • Analyst Decision
  • ILMN Buy
  • TU Buy
  • Analyst Count
  • ILMN 20
  • TU 2
  • Target Price
  • ILMN $160.68
  • TU $26.00
  • AVG Volume (30 Days)
  • ILMN 2.4M
  • TU 3.3M
  • Earning Date
  • ILMN 11-04-2024
  • TU 11-08-2024
  • Dividend Yield
  • ILMN N/A
  • TU 7.39%
  • EPS Growth
  • ILMN N/A
  • TU 14.88
  • EPS
  • ILMN N/A
  • TU 0.46
  • Revenue
  • ILMN $4,390,000,000.00
  • TU $14,777,748,986.00
  • Revenue This Year
  • ILMN N/A
  • TU $3.19
  • Revenue Next Year
  • ILMN $4.28
  • TU $2.80
  • P/E Ratio
  • ILMN N/A
  • TU $34.17
  • Revenue Growth
  • ILMN N/A
  • TU 0.46
  • 52 Week Low
  • ILMN $97.36
  • TU $14.63
  • 52 Week High
  • ILMN $156.66
  • TU $19.14
  • Technical
  • Relative Strength Index (RSI)
  • ILMN 50.63
  • TU 46.47
  • Support Level
  • ILMN $140.56
  • TU $15.15
  • Resistance Level
  • ILMN $146.30
  • TU $15.51
  • Average True Range (ATR)
  • ILMN 4.66
  • TU 0.26
  • MACD
  • ILMN 0.12
  • TU 0.04
  • Stochastic Oscillator
  • ILMN 60.67
  • TU 54.74

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About TU Telus Corporation

Telus is one of the Big Three wireless service providers in Canada, with over 10 million mobile phone subscribers nationwide constituting about 30% of the total market. It is the incumbent local exchange carrier in the western Canadian provinces of British Columbia and Alberta, where it provides internet, television, and landline phone services. It also has a small wireline presence in eastern Quebec. Mostly because of recent acquisitions, more than 20% of Telus' sales now come from nontelecom businesses, most notably in the international business services, health, security, and agriculture industries. The firm has a 55% economic stake in Telus International.

Share on Social Networks: